Outcomes of Breast Cancer Patients Treated with Chemotherapy, Biologic Therapy, Endocrine Therapy, or Active Surveillance During the COVID-19 Pandemic

PURPOSE: Provide real-world data regarding the risk for SARS-CoV-2 infection and mortality in breast cancer (BC) patients on active cancer treatment. METHODS: Clinical data were abstracted from the 3778 BC patients seen at a multisite cancer center in New York between February 1, 2020 and May 1, 202...

Descripción completa

Detalles Bibliográficos
Autores principales: Marks, Douglas K, Budhathoki, Nibash, Kucharczyk, John, Fa’ak, Faisal, D’Abreo, Nina, Kwa, Maryann, Plasilova, Magdalena, Dhage, Shubhada, Soe, Phyu Phyu, Becker, Daniel, Hindenburg, Alexander, Lee, Johanna, Winner, Megan, Okpara, Chinyere, Daly, Alison, Shah, Darshi, Ramdhanny, Angela, Meyers, Marleen, Oratz, Ruth, Speyer, James, Novik, Yelena, Schnabel, Freya, Jones, Simon A, Adams, Sylvia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Breast Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8895753/
https://www.ncbi.nlm.nih.gov/pubmed/35641208
http://dx.doi.org/10.1093/oncolo/oyab042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8895753/
https://www.ncbi.nlm.nih.gov/pubmed/35641208
http://dx.doi.org/10.1093/oncolo/oyab042

Ejemplares similares